Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Faustino, Carolina Brito; Campos, José Ribas Milanez de; Kauffman, Paulo; Leiderman, Dafne Braga Diamante; Tedde, Miguel Lia; Cucato, Gabriel Grizzo; Fernandes, Paulo Pêgo; Leão, Pedro Puech; Wolosker, Nelson

doi:10.1016/j.avsg.2019.04.024

Cited by 10 publications

(8 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[12][13][14][15] Regarding age, ETS for treating HH has proven to be beneficial for a wide range of age groups. 16,17 However, the demand for treatment of hyperhidrosis is estimated to be greater in young and economically active age groups, 5 which is in agreement with our findings, as most individuals in our study were aged between 20 and 39 years (66.2%).…”

Section: Patients' Demographicssupporting

confidence: 90%

Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study

et al. 2022

Self Cite

View full text Add to dashboard Cite

BACKGROUND: Endoscopic thoracic sympathectomy is the definitive surgical treatment for hyperhidrosis and a nationwide study has suggested that cultural and socioeconomic factors play a role in the numbers of operations performed. Thus, there is a need to evaluate local data in order to understand the local epidemiology and trends in hyperhidrosis treatment. OBJECTIVE: To study the epidemiology of sympathectomy for treating hyperhidrosis in São Paulo, the largest city in Brazil. DESIGN AND SETTING: Population-based retrospective cross-sectional study. METHODS: Data on sympathectomies for treating hyperhidrosis between 2008 and 2018 were assessed from the database of the Municipal Health Department of São Paulo, Brazil. RESULTS: 65.29% of the patients were female, 66.2% were aged between 20 and 39 years and 37.59% had registered with addresses outside São Paulo. 1,216 procedures were performed in the city of São Paulo from 2008 to 2018, and 78.45% of them were in only two public hospitals. The number of procedures significantly declined over the years (P = 0.001). 71.63% of the procedures were associated with 2-3 days of hospital stay, only 78 intensive care unit days were billed and we did not observe any intra-hospital death. CONCLUSION: The profile of patients operated on in São Paulo (young women) is similar to that described in other populations. Sympathectomy is a very safe procedure, with no mortality in our series. There was a decreasing trend in the number of surgeries over the years.

show abstract

Section: Patients' Demographicssupporting

confidence: 90%

Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Regarding age, ETS to treat HH has proven to be beneficial for a wide range of age groups (16,17). However, the demand for treatment of hyperhidrosis is estimated to be greater in young and economically active age groups(5), which is in agreement with our findings, as most individuals in our study were aged between 20 and 39 years (66.2%).…”

Section: Patients' Demographicssupporting

confidence: 90%

Population-based Cross-sectional Analysis of the Epidemiology of the Surgical Correction of Hyperhidrosis in 1216 Patients over 11 years

Silva

Louzada

Teivelis

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Endoscopic thoracic sympathectomy is the definitive surgical treatment for hyperhidrosis, and a nationwide study suggested that it has been performed in a higher rate than which could have been expected due to climate characteristics, comparing to the national statistics. Objectives: To study the epidemiology of sympathectomy to treat hyperhidrosis in Sao Paulo, the largest city in the Southeast. Design and setting: population-based cross-sectional study. Methods: data on sympathectomies to treat hyperhidrosis between 2008 and 2018 were assessed from the database of the Municipal Health Secretary of Sao Paulo, Brazil. Results: 65.29% of the patients were female, 66.2% aged between 20 and 39 years and 37.59% had addresses registered outside Sao Paulo. 1216 procedures were performed in the city of Sao Paulo from 2008 to 2018, 78.45% of which in only two public hospitals. The number of procedures significantly declined over the years (p = 0.001). 71.63% of the procedures were associated with 2 to 3 days of hospital stay, only 78 intensive care unit days were billed and we did not observe any intra-hospital death. Conclusions: sympathectomies for the treatment of HH were widely performed in the city of Sao Paulo (1216 procedures), mainly in young (20 to 39 years) and female patients, with more than one third of the patients having addresses registered outside the city. This is a very safe surgery, with low need for intensive care units and no mortality in our series. There was a decreasing trend in the number of surgeries over the years.

show abstract

“…In our institution, oxybutynin is used as a first-line treatment. Oxybutynin is indicated for both sexes (13) unlike surgery, and it can be used to treat patients of all age groups (11,(29)(30)(31) and obese and nonobese patients (32). It yields good results (improves sweating in more than 70% of patients) in the short and long term (33)(34)(35).…”

Section: ' Discussionmentioning

confidence: 99%

Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin

Kamikava

Wolosker

Silva

et al. 2021

Clinics

Self Cite

View full text Add to dashboard Cite

Studies have identified correlations between the psychological characteristics of individuals with primary hyperhidrosis (HH), the degree of sweating, and the quality of life (QoL). This study aimed to evaluate the prevalence of anxiety and depression symptoms in patients with HH before and after oxybutynin treatment. METHODS: Data were collected from 81 patients. Palmar or axillary HH was the most frequent complaint (84.0%). All patients were evaluated before the medication was prescribed and after five weeks of treatment. The Beck Depression Inventory and Beck Anxiety Inventory were used to evaluate depression and anxiety. RESULTS: Improvement in HH occurred in 58 patients (71.6%), but there was no improvement in 23 patients (28.4%). The QoL before treatment in all patients was either ''poor'' or ''very poor.'' Patients who experienced improvement in sweating rates also experienced a greater improvement in QoL than patients who did not experience improvement in sweating at the main site (87.9% vs. 34.7%) (po0.001). A total of 19.7% of patients showed an improvement in their level of depression, and a total of 46.9% of patients exhibited improvements in their level of anxiety. A significant correlation was observed between sweating and anxiety (p=0.015). CONCLUSION: Patients with HH who experienced improvements in sweating immediately after treatment with oxybutynin exhibited small improvements in their levels of depression and significant improvements in their levels of anxiety and QoL.

show abstract

Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Abstract: Nelson (2020) Analysis of the results of videotoracoscopic sympathectomy in the treatment of hyperhidrosis in patients 40 years or older. Annals of Vascular Surgery, 65. pp. 107-112.

Cited by 10 publications

References 18 publications

Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study

Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study

Population-based Cross-sectional Analysis of the Epidemiology of the Surgical Correction of Hyperhidrosis in 1216 Patients over 11 years

Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin

Contact Info

Product

Resources

About